Silvan Boxler

4.9k total citations · 1 hit paper
26 papers, 1.5k citations indexed

About

Silvan Boxler is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Silvan Boxler has authored 26 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Silvan Boxler's work include Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (14 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Silvan Boxler is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (19 papers), Prostate Cancer Treatment and Research (14 papers) and Bladder and Urothelial Cancer Treatments (8 papers). Silvan Boxler collaborates with scholars based in Switzerland, Germany and United Kingdom. Silvan Boxler's co-authors include Boris Hadaschik, Ali Afshar‐Oromieh, Tim Holland‐Letz, Uwe Haberkorn, Klaus Kopka, Clemens Kratochwil, Wilko Weichert, Jürgen Debus, Michael Eisenhut and Heinz Linhart and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and American Journal Of Pathology.

In The Last Decade

Silvan Boxler

24 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer

2014 785 citations Ali Afshar‐Oromieh, Frederik L. Giesel et al. European Journal of Nuclear Medicine and Molecular Imaging profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Silvan Boxler Switzerland	14	1.4k	824	341	166	134	26	1.5k
Daniel Christidis Australia	9	1.4k 1.1×	732 0.9×	324 1.0×	173 1.0×	134 1.0×	24	1.6k
SUSAN D. SWEAT United States	10	565 0.4×	296 0.4×	275 0.8×	137 0.8×	261 1.9×	16	922
Bao Ho Australia	20	1.9k 1.4×	1.2k 1.5×	361 1.1×	228 1.4×	62 0.5×	42	2.1k
Roel A. M. Heesakkers Netherlands	7	933 0.7×	519 0.6×	283 0.8×	69 0.4×	123 0.9×	11	1.1k
Jost von Hardenberg Germany	16	485 0.4×	160 0.2×	136 0.4×	96 0.6×	130 1.0×	67	777
Bas Israël Netherlands	12	1.2k 0.9×	571 0.7×	379 1.1×	54 0.3×	88 0.7×	21	1.3k
Thomas A. Stamey United States	12	1.1k 0.8×	106 0.1×	403 1.2×	118 0.7×	176 1.3×	15	1.3k
Nina-Sophie Schmidt-Hegemann Germany	20	1.0k 0.7×	635 0.8×	84 0.2×	204 1.2×	104 0.8×	74	1.3k
Emre Demirci Türkiye	16	827 0.6×	710 0.9×	122 0.4×	378 2.3×	92 0.7×	53	1.2k
Franz Stoiber Austria	6	627 0.5×	397 0.5×	182 0.5×	90 0.5×	334 2.5×	12	910

Countries citing papers authored by Silvan Boxler

Since Specialization

Citations

This map shows the geographic impact of Silvan Boxler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvan Boxler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvan Boxler more than expected).

Fields of papers citing papers by Silvan Boxler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvan Boxler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvan Boxler. The network helps show where Silvan Boxler may publish in the future.

Co-authorship network of co-authors of Silvan Boxler

This figure shows the co-authorship network connecting the top 25 collaborators of Silvan Boxler. A scholar is included among the top collaborators of Silvan Boxler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvan Boxler. Silvan Boxler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Furrer, Marc A., Bernhard Kiss, Urs E. Studer, et al.. (2021). Seminal Vesical Sparing Cystectomy for Bladder Cancer is Feasible with Good Functional Results without Impairing Oncological Outcomes: A Longitudinal Long-Term Propensity-Matched Single Center Study. The Journal of Urology. 205(6). 1629–1640. 5 indexed citations

Huber, Philipp, Naveed Afzal, Manit Arya, et al.. (2020). Focal HIFU therapy for anterior compared to posterior prostate cancer lesions. World Journal of Urology. 39(4). 1115–1119. 32 indexed citations

Huber, Philipp, Naveed Afzal, Manit Arya, et al.. (2020). An Exploratory Study of Dose Escalation vs Standard Focal High-Intensity Focused Ultrasound for Treating Nonmetastatic Prostate Cancer. Journal of Endourology. 34(6). 641–646. 5 indexed citations

Huber, Philipp, Naveed Afzal, Manit Arya, et al.. (2020). Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound. The Journal of Urology. 203(4). 734–742. 38 indexed citations

Alberts, Ian, Christos Sachpekidis, Eleni Gourni, et al.. (2019). Dynamic patterns of [68Ga]Ga-PSMA-11 uptake in recurrent prostate cancer lesions. European Journal of Nuclear Medicine and Molecular Imaging. 47(1). 160–167. 25 indexed citations

Alberts, Ian, Christos Sachpekidis, George Prenosil, et al.. (2019). The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia. European Journal of Nuclear Medicine and Molecular Imaging. 47(3). 642–651. 31 indexed citations

Alberts, Ian, Christos Sachpekidis, Silvan Boxler, et al.. (2019). 68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer—a modified protocol compared with the common protocol. European Journal of Nuclear Medicine and Molecular Imaging. 47(3). 624–631. 29 indexed citations

Afshar‐Oromieh, Ali, Bernd Vollnberg, Ian Alberts, et al.. (2019). Comparison of PSMA-ligand PET/CT and multiparametric MRI for the detection of recurrent prostate cancer in the pelvis. European Journal of Nuclear Medicine and Molecular Imaging. 46(11). 2289–2297. 18 indexed citations

Furrer, Marc A., Antoni Vilaseca, Renato B. Corradi, et al.. (2018). Repeat prostate biopsies prior to radical prostatectomy do not impact erectile function recovery and mid‐ to long‐term continence. The Prostate. 78(8). 631–636. 1 indexed citations

10.

Spahn, Martin, Alessandro Morlacco, Silvan Boxler, et al.. (2017). Outcome predictors of radical cystectomy in patients with cT 4 prostate cancer: a multi‐institutional study of 62 patients. British Journal of Urology. 120(5B). E52–E58. 7 indexed citations

11.

Spahn, Martin, et al.. (2017). PSA-recurrence after radical prostatectomy for intermediate/high risk prostate cancer: A helpful parameter or just a patient stress amplifier.. Journal of Clinical Oncology. 35(15_suppl). e16535–e16535.

12.

Radtke, Jan Philipp, Timur H. Kuru, David Bonekamp, et al.. (2016). Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance. Prostate Cancer and Prostatic Diseases. 19(3). 283–291. 44 indexed citations

13.

Kesch, Claudia, Jan Philipp Radtke, Florian Distler, et al.. (2016). Wertigkeit der multiparametrischen MRT und der MRT-TRUS-Fusionsbiopsie bei primär negativ biopsierten Patienten. Der Urologe. 55(8). 1071–1077. 5 indexed citations

14.

Barbieri, Sebastiano, Michael P. Brönnimann, Silvan Boxler, Peter Vermathen, & Harriet C. Thoeny. (2016). Differentiation of prostate cancer lesions with high and with low Gleason score by diffusion-weighted MRI. European Radiology. 27(4). 1547–1555. 40 indexed citations

15.

Radtke, Jan Philipp, Silvan Boxler, Timur H. Kuru, et al.. (2015). Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance. Prostate Cancer and Prostatic Diseases. 18(3). 288–296. 68 indexed citations

16.

Spahn, Martin, Silvan Boxler, Steven Joniau, et al.. (2015). What is the Need for Prostatic Biomarkers in Prostate Cancer Management?. Current Urology Reports. 16(10). 70–70. 10 indexed citations

17.

Afshar‐Oromieh, Ali, Frederik L. Giesel, Tim Holland‐Letz, et al.. (2014). The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 42(2). 197–209. 785 indexed citations breakdown →

18.

Kuru, Timur H., Matthias Roethke, Silvan Boxler, et al.. (2013). 222 Detecting clinically significant prostate cancer by MRI-targeted TRUS-guided transperineal fusion biopsy. European Urology Supplements. 12(1). e222–e222. 1 indexed citations

19.

Boxler, Silvan, Valentin Djonov, Thomas M. Kessler, et al.. (2010). Matrix Metalloproteinases and Angiogenic Factors. American Journal Of Pathology. 177(5). 2216–2224. 28 indexed citations

20.

Thalmann, G.N., Frédéric D. Birkhaeuser, Silvan Boxler, Fiona C. Burkhard, & Urs E. Studer. (2009). 535 RADICAL CYSTECTOMY WITH EXTENDED PELVIC LYMPH NODE DISSECTION IN OVER 1000 PATIENTS: GOOD SURVIVAL AND LOW LOCAL RECURRENCE RATES. European Urology Supplements. 8(4). 254–254.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact